Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-392,700
Closed -$13.7M – 6164
2020
Q4
$13.7M Buy
392,700
+61,300
+18% +$1.73M 0.01% 1311
2020
Q3
$5.74M Sell
331,400
-4,700
-1% -$81.9K ﹤0.01% 1794
2020
Q2
$5.52M Sell
336,100
-103,800
-24% -$1.58M ﹤0.01% 1777
2020
Q1
$3.99M Buy
439,900
+253,200
+136% +$5.1M ﹤0.01% 1865
2019
Q4
$3.97M Sell
186,700
-84,100
-31% -$1.87M ﹤0.01% 2244
2019
Q3
$6.22M Buy
270,800
+83,200
+44% +$1.9M ﹤0.01% 1748
2019
Q2
$4.55M Sell
187,600
-31,000
-14% -$638K ﹤0.01% 2048
2019
Q1
$2.83M Buy
218,600
+121,400
+125% +$2.13M ﹤0.01% 2295
2018
Q4
$1.46M Buy
97,200
+92,700
+2,060% +$2.4M ﹤0.01% 2990
2018
Q3
$177K Buy
+4,500
New +$203K ﹤0.01% 5381

Other funds holding ADNT

Citigroup's ADNT Position: Q3 2026 in Review

Citigroup reduced its Adient (ADNT) stake by 26% in Q3 2026, selling an estimated $497K and leaving 74,897 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

Citigroup first reported a position in ADNT in Q4 2016 and has held it in 40 quarters since. The position peaked at $29M in Q4 2018. 304 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

  • Citigroup held 74,897 shares of Adient worth $1.26M as of Q3 2026.
  • Citigroup sold 25,800 Adient shares in Q3 2026, an estimated $497K.
  • Adient made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3158 holding.
  • Citigroup first reported a position in Adient in Q4 2016 and has held it in 40 quarters since.
  • Citigroup's Adient position peaked at $29M in Q4 2018.
  • 304 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.